WHO Seeks 'Additional Clarifications' From Bharat Biotech For Covaxin To Conduct Final 'Risk-Benefit Assessment'
WHO Chief Discusses Covaxin Listing, Resumption Of AstraZeneca Vaccine Supplies With Health Minister Mandaviya
Bharat Biotech Calls Out ‘Covishield vs Covaxin’ Comparative Study, Adds That Report Had Lot Of Flaws
Bharat Biotech’s Covaxin Shows 78 Percent Efficacy In Phase 3 Analysis
